6D4D
Crystal structure of the PTP epsilon D1 domain
6D4D の概要
| エントリーDOI | 10.2210/pdb6d4d/pdb |
| 分子名称 | Receptor-type tyrosine-protein phosphatase epsilon (2 entities in total) |
| 機能のキーワード | phosphatase, hydrolase |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 67831.86 |
| 構造登録者 | Lountos, G.T.,Raran-Kurussi, S.,Zhao, B.M.,Dyas, B.K.,Austin, B.P.,Burke Jr., T.R.,Ulrich, R.G.,Waugh, D.S. (登録日: 2018-04-18, 公開日: 2018-10-17, 最終更新日: 2024-10-30) |
| 主引用文献 | Lountos, G.T.,Raran-Kurussi, S.,Zhao, B.M.,Dyas, B.K.,Burke Jr., T.R.,Ulrich, R.G.,Waugh, D.S. High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design. Acta Crystallogr D Struct Biol, 74:1015-1026, 2018 Cited by PubMed Abstract: Here, new crystal structures are presented of the isolated membrane-proximal D1 and distal D2 domains of protein tyrosine phosphatase epsilon (PTPℇ), a protein tyrosine phosphatase that has been shown to play a positive role in the survival of human breast cancer cells. A triple mutant of the PTPℇ D2 domain (A455N/V457Y/E597D) was also constructed to reconstitute the residues of the PTPℇ D1 catalytic domain that are important for phosphatase activity, resulting in only a slight increase in the phosphatase activity compared with the native D2 protein. The structures reported here are of sufficient resolution for structure-based drug design, and a microarray-based assay for high-throughput screening to identify small-molecule inhibitors of the PTPℇ D1 domain is also described. PubMed: 30289412DOI: 10.1107/S2059798318011919 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.765 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






